Novartis India

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE234A01025
  • NSEID: NOVARTIND
  • BSEID: 500672
INR
1,295.10
-8.75 (-0.67%)
BSENSE

Jun 15, 03:30 PM

BSE+NSE Vol: 16.93 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 333626,
    "name": "Novartis India",
    "stock_name": "Novartis India",
    "full_name": "Novartis India Ltd",
    "name_url": "stocks-analysis/novartis-india",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,295.10",
    "chg": -8.75,
    "chgp": "-0.67%",
    "dir": -1,
    "prev_price": "1,303.85",
    "mcapval": "3,206.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 500672,
    "symbol": "NOVARTIND",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE234A01025",
    "curr_date": "Jun 15, 03:30 PM",
    "curr_time": "19:40 PM",
    "last_traded_at": "Jun 15, 03:30 PM IST",
    "bse_nse_vol": "16.93 k",
    "exc_status": "Active",
    "traded_date": "Jun 15, 2026",
    "traded_date_str": "2026 06 15",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/novartis-india-333626-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Novartis India Ltd Falls 10.71%: 3 Key Factors Driving the Weekly Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-ltd-falls-1071-3-key-factors-driving-the-weekly-decline-4053012",
        "imagepath": "",
        "date": "2026-06-14 13:00:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> New 52-week and all-time high at Rs.1,588.40</p>\n                    <p><strong>3 June:</strong> Intraday low amid heavy price pressure at Rs.1,360</p>\n                    <p><strong>5 June:</strong> Week closes at Rs.1,388.90, down 10.71%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,555.45</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,388.90</div><div class=\"stat-change negative\">-10.71%</div></div>\n                    <div class=\"stat-item\"><div class=\"s..."
      },
      {
        "title": "Novartis India Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novartis-india-ltd-is-rated-hold-4052716",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NovartisIndiaLt_mojoScore_4052716.png",
        "date": "2026-06-14 10:10:41",
        "description": "Novartis India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 14 June 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Novartis India Ltd Hits Intraday Low Amid Price Pressure on 3 June 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-ltd-hits-intraday-low-amid-price-pressure-on-3-june-2026-4033737",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NovartisIndiaLt_priceRelatedfactors_4033737.png",
        "date": "2026-06-03 10:31:25",
        "description": "Novartis India Ltd experienced a notable decline today, touching an intraday low of Rs 1360, reflecting a sharp price correction amid broader market weakness and sector underperformance. The stock’s downward trajectory was marked by a 7.16% fall from its previous close, underscoring immediate selling pressure and cautious sentiment among market participants."
      },
      {
        "title": "Novartis India Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novartis-india-ltd-is-rated-hold-4033371",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NovartisIndiaLt_mojoScore_4033371.png",
        "date": "2026-06-03 10:11:38",
        "description": "Novartis India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 June 2026, providing investors with an up-to-date perspective on the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Novartis India Ltd to 52-Week High of Rs 1588.4",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-ltd-hits-new-52-week-high-at-rs15884-4025805",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NovartisIndiaLt_priceRelatedfactors_4025805.png",
        "date": "2026-06-01 09:48:07",
        "description": "Surging to a new 52-week high of Rs 1588.4 on 1 Jun 2026, Novartis India Ltd has demonstrated remarkable price momentum, outperforming the Sensex by a wide margin over the past year. This milestone caps a 47.29% rally from its 52-week low of Rs 750, underscoring a sustained uptrend fuelled by strong technical signals across multiple timeframes."
      },
      {
        "title": "Strong Momentum Meets Stretched Valuations as Novartis India Ltd Reaches All-Time High",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-ltd-stock-hits-all-time-high-at-rs-158840-4025735",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NovartisIndiaLt_priceRelatedfactors_4025735.png",
        "date": "2026-06-01 09:33:11",
        "description": ""
      },
      {
        "title": "Novartis India Ltd Gains 14.16%: 8 Key Factors Driving the Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-ltd-gains-1416-8-key-factors-driving-the-surge-4024151",
        "imagepath": "",
        "date": "2026-05-31 09:00:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>25 May:</strong> New 52-week high at Rs.1,424.9 and all-time high near Rs.1,422.25</p>\n                    <p><strong>26 May:</strong> New 52-week high at Rs.1,430 and all-time high at Rs.1,425.00</p>\n                    <p><strong>27 May:</strong> New 52-week high at Rs.1,462.5 and all-time high at Rs.1,458</p>\n                    <p><strong>29 May:</strong> New 52-week and all-time high at Rs.1,496.85 and Rs.1,497.35</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,362.55</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">W..."
      },
      {
        "title": "From Steady Gains to Record Close: Novartis India Ltd Hits All-Time High at Rs 1,497.35",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-ltd-stock-hits-all-time-high-at-rs149735-4019901",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NovartisIndiaLt_priceRelatedfactors_4019901.png",
        "date": "2026-05-29 10:06:20",
        "description": "Extending its remarkable rally, Novartis India Ltd touched a fresh all-time high of Rs 1,497.35 on 29 May 2026, marking a significant milestone in its multi-year ascent that has outpaced the broader market by a wide margin."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Novartis India Ltd to 52-Week High of Rs 1496.85",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-ltd-hits-new-52-week-high-at-rs149685-4019608",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NovartisIndiaLt_priceRelatedfactors_4019608.png",
        "date": "2026-05-29 09:44:54",
        "description": "With a decisive break above Rs 1496.85 on 29 Jun 2026, Novartis India Ltd has reached a fresh 52-week high, extending its impressive 39.98% return over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained gains over the last three trading sessions, signalling robust price action in the pharmaceuticals sector."
      }
    ],
    "total": 268,
    "sid": "333626",
    "stock_news_url": "https://www.marketsmojo.com/news/novartis-india-333626"
  },
  "announcements": [
    {
      "caption": "Updates on Open Offer",
      "datetime": "12-Jun-2026",
      "details": "Axis Capital Ltd (Manager to the Open Offer) has informed BSE regarding Open offer for acquisition of up to 6419608 (sixty four lakhs nineteen thousand six hundred and eight) fully paid-up equity shares of face value of INR 5 each (Equity Shares) from the Public Shareholders of Novartis India Ltd (Target Company) representing 26% of the Voting Share Capital of the Target Company by WaveRise Investments Limited (Acquirer 1) ChrysCapital Fund X the first scheme of ChrysCapital Trust I a category II alternative investment fund registered with the Securities and Exchange Board of India (Acquirer 2) and Two Infinity Partners (Acquirer 3) (Acquirer 1 Acquirer 2 and Acquirer 3 collectively referred to as the Acquirers) along with ChrysCapital X LLC (PAC 1) and OceanEdge Investments Limited (PAC 2) (PAC 1 and PAC 2 collectively referred to as the PACs) in their capacity as persons acting in concert with the Acquirers (Open Offer).",
      "source": "BSE"
    },
    {
      "caption": "Pre-Offer Advertisement & Corrigendum to Detailed Public Statement",
      "datetime": "11-Jun-2026",
      "details": "Axis Capital Ltd (Manager to the Open Offer) has submitted to BSE a copy of Pre-Offer Advertisement in accordance with Regulation 18(7) of The Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 as amended and corrigendum to the detailed Public Statement for the attention of the Public Shareholders of Novartis India Ltd (Target Company).",
      "source": "BSE"
    },
    {
      "caption": "Updates on Open Offer",
      "datetime": "11-Jun-2026",
      "details": "Axis Capital Ltd (Manager to the Open Offer) has informed BSE regarding the updates on Open offer for acquisition of up to 6419608 (sixty four lakhs nineteen thousand six hundred and eight) fully paid-up equity shares of face value of INR 5 each (Equity Shares) from the Public Shareholders of Novartis India Ltd (Target Company) representing 26% of the Voting Share Capital of the Target Company by WaveRise Investments Ltd (Acquirer 1) ChrysCapital Fund X the first scheme of ChrysCapital Trust I a category II alternative investment fund registered with the Securities and Exchange Board of India (Acquirer 2) and Two Infinity Partners (Acquirer 3) (Acquirer 1 Acquirer 2 and Acquirer 3 collectively referred to as the Acquirers) along with ChrysCapital X LLC (PAC 1) and OceanEdge Investments Ltd (PAC 2) (PAC 1 and PAC 2 collectively referred to as the PACs) in their capacity as persons acting in concert with the Acquirers (Open Offer).",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Novartis India Ltd has declared <strong>500%</strong> dividend, ex-date: 23 Jul 25",
          "dt": "2025-07-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Novartis India Ltd Falls 10.71%: 3 Key Factors Driving the Weekly Decline

2026-06-14 13:00:07

Key Events This Week

1 June: New 52-week and all-time high at Rs.1,588.40

3 June: Intraday low amid heavy price pressure at Rs.1,360

5 June: Week closes at Rs.1,388.90, down 10.71%

stock-recommendationAnnouncement

Updates on Open Offer

12-Jun-2026 | Source : BSE

Axis Capital Ltd (Manager to the Open Offer) has informed BSE regarding Open offer for acquisition of up to 6419608 (sixty four lakhs nineteen thousand six hundred and eight) fully paid-up equity shares of face value of INR 5 each (Equity Shares) from the Public Shareholders of Novartis India Ltd (Target Company) representing 26% of the Voting Share Capital of the Target Company by WaveRise Investments Limited (Acquirer 1) ChrysCapital Fund X the first scheme of ChrysCapital Trust I a category II alternative investment fund registered with the Securities and Exchange Board of India (Acquirer 2) and Two Infinity Partners (Acquirer 3) (Acquirer 1 Acquirer 2 and Acquirer 3 collectively referred to as the Acquirers) along with ChrysCapital X LLC (PAC 1) and OceanEdge Investments Limited (PAC 2) (PAC 1 and PAC 2 collectively referred to as the PACs) in their capacity as persons acting in concert with the Acquirers (Open Offer).

Pre-Offer Advertisement & Corrigendum to Detailed Public Statement

11-Jun-2026 | Source : BSE

Axis Capital Ltd (Manager to the Open Offer) has submitted to BSE a copy of Pre-Offer Advertisement in accordance with Regulation 18(7) of The Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 as amended and corrigendum to the detailed Public Statement for the attention of the Public Shareholders of Novartis India Ltd (Target Company).

Updates on Open Offer

11-Jun-2026 | Source : BSE

Axis Capital Ltd (Manager to the Open Offer) has informed BSE regarding the updates on Open offer for acquisition of up to 6419608 (sixty four lakhs nineteen thousand six hundred and eight) fully paid-up equity shares of face value of INR 5 each (Equity Shares) from the Public Shareholders of Novartis India Ltd (Target Company) representing 26% of the Voting Share Capital of the Target Company by WaveRise Investments Ltd (Acquirer 1) ChrysCapital Fund X the first scheme of ChrysCapital Trust I a category II alternative investment fund registered with the Securities and Exchange Board of India (Acquirer 2) and Two Infinity Partners (Acquirer 3) (Acquirer 1 Acquirer 2 and Acquirer 3 collectively referred to as the Acquirers) along with ChrysCapital X LLC (PAC 1) and OceanEdge Investments Ltd (PAC 2) (PAC 1 and PAC 2 collectively referred to as the PACs) in their capacity as persons acting in concert with the Acquirers (Open Offer).

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Novartis India Ltd has declared 500% dividend, ex-date: 23 Jul 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available